Summary
Updated Aug 31, 2026
Chris Freeman is Chief Commercial Officer of Guardant Health, Inc. (GH). 13 SEC Form 4 filings on record going back to 2024, most recently on 11 August 2026. Most recent open-market trade: sold $2.96M of GH on 11 August 2026. Lifetime open-market sales: $13.68M.
Recent Transactions
20Every recent SEC Form 4 transaction Chris Freeman has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Chris Freeman go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Chris Freeman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amirali Talasaz - $73.75M of GH open-market activity in the last 12 months
- Helmy Eltoukhy - $30.47M of GH open-market activity in the last 12 months
- Terilyn J. Monroe - $14.82M of GH open-market activity in the last 12 months
- Kumud Kalia - $5.15M of GH open-market activity in the last 12 months
- John G. Saia - $4.25M of GH open-market activity in the last 12 months
- Ian T. Clark - $2.99M of GH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Chris Freeman?
Chris Freeman is a corporate insider, tracked as Chief Commercial Officer of Guardant Health, Inc. (GH). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Chris Freeman submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Chris Freeman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($13.68M) across all tracked filings.
Where can I see all of Chris Freeman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Chris Freeman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial